Milbemycin Oxime: A Comprehensive Guide to its Veterinary Applications and Benefits

Discover the key uses and advantages of Milbemycin Oxime in protecting your pets from harmful parasites.

Get a Quote & Sample

Key Advantages Provided

Broad-Spectrum Efficacy

The extensive antiparasitic action of milbemycin oxime covers a wide array of nematodes and mites, offering robust protection for pets.

Convenient Administration

As a monthly oral tablet, milbemycin oxime simplifies parasite prevention schedules, ensuring consistent protection for dogs and cats.

Proven Safety Profile

When used as directed and with appropriate veterinary guidance, milbemycin oxime is generally well-tolerated by most animals, including puppies and kittens.

Key Applications

Heartworm Disease Prevention

Administering milbemycin oxime monthly is the standard for preventing heartworm disease, a serious and potentially deadly condition in dogs and cats.

Intestinal Parasite Control

Milbemycin oxime effectively removes and controls common intestinal parasites such as hookworms, roundworms, and whipworms in dogs and cats.

Mite Infestation Treatment

Off-label use of milbemycin oxime is recognized for treating various mite infestations, including demodectic and sarcoptic mange in dogs.

Combination Therapies

Milbemycin oxime is frequently combined with other active ingredients to broaden its antiparasitic spectrum, offering comprehensive protection.

Why Choose Us?

Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.

Global Experience

With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.

Advanced Facilities

Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.

Seamless Scalability

We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).